• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 2D 和 3D HepaRG 细胞模型评估八种亚硝胺的遗传毒性。

Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.

机构信息

Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA.

Wiess School of Natural Sciences, Rice University, Houston, TX, 77005, USA.

出版信息

Arch Toxicol. 2023 Oct;97(10):2785-2798. doi: 10.1007/s00204-023-03560-x. Epub 2023 Jul 24.

DOI:10.1007/s00204-023-03560-x
PMID:37486449
Abstract

N-nitrosamine impurities have been increasingly detected in human drugs. This is a safety concern as many nitrosamines are mutagenic in bacteria and carcinogenic in rodent models. Typically, the mutagenic and carcinogenic activity of nitrosamines requires metabolic activation by cytochromes P450 enzymes (CYPs), which in many in vitro models are supplied exogenously using rodent liver homogenates. There are only limited data on the genotoxicity of nitrosamines in human cell systems. In this study, we used metabolically competent human HepaRG cells, whose metabolic capability is comparable to that of primary human hepatocytes, to evaluate the genotoxicity of eight nitrosamines [N-cyclopentyl-4-nitrosopiperazine (CPNP), N-nitrosodibutylamine (NDBA), N-nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-nitrosodiisopropylamine (NDIPA), N-nitrosoethylisopropylamine (NEIPA), N-nitroso-N-methyl-4-aminobutyric acid (NMBA), and N-nitrosomethylphenylamine (NMPA)]. Under the conditions we used to culture HepaRG cells, three-dimensional (3D) spheroids possessed higher levels of CYP activity compared to 2D monolayer cells; thus the genotoxicity of the eight nitrosamines was investigated using 3D HepaRG spheroids in addition to more conventional 2D cultures. Genotoxicity was assessed as DNA damage using the high-throughput CometChip assay and as aneugenicity/clastogenicity in the flow-cytometry-based micronucleus (MN) assay. Following a 24-h treatment, all the nitrosamines induced DNA damage in 3D spheroids, while only three nitrosamines, NDBA, NDEA, and NDMA, produced positive responses in 2D HepaRG cells. In addition, these three nitrosamines also caused significant increases in MN frequency in both 2D and 3D HepaRG models, while NMBA and NMPA were positive only in the 3D HepaRG MN assay. Overall, our results indicate that HepaRG spheroids may provide a sensitive, human-based cell system for evaluating the genotoxicity of nitrosamines.

摘要

N-亚硝胺杂质在人类药物中越来越多地被检测到。这是一个安全隐患,因为许多亚硝胺在细菌中具有致突变性,在啮齿动物模型中具有致癌性。通常,亚硝胺的致突变性和致癌活性需要细胞色素 P450 酶(CYPs)的代谢激活,在许多体外模型中,这些酶是使用鼠肝匀浆外源性提供的。关于亚硝胺在人类细胞系统中的遗传毒性仅有有限的数据。在这项研究中,我们使用代谢能力强的人 HepaRG 细胞,其代谢能力与原代人肝细胞相当,来评估八种亚硝胺[N-环戊基-4-亚硝基哌嗪(CPNP)、N-亚硝二丁胺(NDBA)、N-亚硝二乙胺(NDEA)、N-亚硝二甲胺(NDMA)、N-亚硝二异丙胺(NDIPA)、N-亚硝基乙基异丙胺(NEIPA)、N-亚硝基-N-甲基-4-氨基丁酸(NMBA)和 N-亚硝基甲基苯胺(NMPA)]的遗传毒性。在我们用于培养 HepaRG 细胞的条件下,三维(3D)球体比 2D 单层细胞具有更高水平的 CYP 活性;因此,除了更传统的 2D 培养外,我们还使用 3D HepaRG 球体研究了这八种亚硝胺的遗传毒性。使用高通量彗星芯片测定法评估遗传毒性作为 DNA 损伤,并用基于流式细胞术的微核(MN)测定法评估有丝分裂后期加倍/断裂剂的遗传毒性。经过 24 小时处理,所有亚硝胺均在 3D 球体中诱导 DNA 损伤,而只有三种亚硝胺(NDBA、NDEA 和 NDMA)在 2D HepaRG 细胞中产生阳性反应。此外,这三种亚硝胺还导致 2D 和 3D HepaRG 模型中 MN 频率显著增加,而 NMBA 和 NMPA 仅在 3D HepaRG MN 测定中呈阳性。总体而言,我们的结果表明 HepaRG 球体可能为评估亚硝胺的遗传毒性提供一种敏感的基于人类的细胞系统。

相似文献

1
Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.使用 2D 和 3D HepaRG 细胞模型评估八种亚硝胺的遗传毒性。
Arch Toxicol. 2023 Oct;97(10):2785-2798. doi: 10.1007/s00204-023-03560-x. Epub 2023 Jul 24.
2
Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.使用转染细胞色素 P450 的人 TK6 细胞对亚硝胺杂质进行遗传毒性评估。
Arch Toxicol. 2022 Nov;96(11):3077-3089. doi: 10.1007/s00204-022-03347-6. Epub 2022 Jul 26.
3
Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models.使用二维和三维HepaRG细胞模型对十种亚硝胺类药物相关杂质进行遗传毒性评估。
Regul Toxicol Pharmacol. 2025 Nov;162:105906. doi: 10.1016/j.yrtph.2025.105906. Epub 2025 Jul 9.
4
Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes.八种亚硝胺在原代人肝细胞和猕猴肝细胞中诱导的DNA损伤比较
Chem Biol Interact. 2025 Aug 1;416:111538. doi: 10.1016/j.cbi.2025.111538. Epub 2025 May 2.
5
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities.将大鼠肝脏微核试验整合到28天治疗方案中:测试4种具有不同致癌潜力和肿瘤靶标特异性的小分子亚硝胺的遗传毒性。
Toxicol Sci. 2025 Aug 1;206(2):409-419. doi: 10.1093/toxsci/kfaf002.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
A New Analytical LC-MS/MS Method for Determination of Eight Standard Nitrosamines (NDMA, NMBA, NDEA, NEIPA, NDIPA, NMPA, NDPA, NDBA) in a Commercial Small Molecule Drug Product Capsules and its Active Pharmaeceutical Ingredient for Treatment of Fabry: A Rare Disease.一种用于测定商业小分子药品胶囊及其活性药物成分中八种标准亚硝胺(N-亚硝基二甲胺、N-亚硝基甲基苄胺、N-亚硝基二乙胺、N-亚硝基-N-乙基异丙胺、N-亚硝基-N-二异丙胺、N-亚硝基-N-甲基苯乙胺、N-亚硝基-N,N-二丙胺、N-亚硝基-N,N-二丁胺)的新型分析液相色谱-串联质谱法,该药品用于治疗法布里病:一种罕见病。
Pharm Res. 2025 Jun 17. doi: 10.1007/s11095-025-03875-7.
8
Application of HepaRG cells for genotoxicity assessment: a review.HepaRG 细胞在遗传毒性评估中的应用:综述。
J Environ Sci Health C Toxicol Carcinog. 2024;42(3):214-237. doi: 10.1080/26896583.2024.2331956. Epub 2024 Apr 2.
9
Genetic toxicity assessment using liver cell models: past, present, and future.利用肝细胞模型进行遗传毒性评估:过去、现在和未来。
J Toxicol Environ Health B Crit Rev. 2020;23(1):27-50. doi: 10.1080/10937404.2019.1692744. Epub 2019 Nov 20.
10
Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.使用纠错的下一代测序技术评估 N-亚硝基二甲胺在 2D 和 3D HepaRG 细胞培养物中的致突变性。
Arch Toxicol. 2024 Jun;98(6):1919-1935. doi: 10.1007/s00204-024-03731-4. Epub 2024 Apr 7.

引用本文的文献

1
Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination.通过纠错下一代测序和DNA甲基化定量分析对小鼠体内N-亚硝基二甲胺进行定量遗传毒性评估以确定毒性阈值。
Arch Toxicol. 2025 Aug 24. doi: 10.1007/s00204-025-04166-1.
2
Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen.人类HepaRG细胞长期暴露于基因毒性致癌物后的突变积累。
J Environ Sci Health C Toxicol Carcinog. 2025 Aug 22:1-23. doi: 10.1080/26896583.2025.2548146.
3
Development of a TK6-derived cell line expressing four human cytochrome P450s for genotoxicity testing.

本文引用的文献

1
Risk assessment of nitrosamines in food.食品中亚硝胺的风险评估。
EFSA J. 2023 Mar 28;21(3):e07884. doi: 10.2903/j.efsa.2023.7884. eCollection 2023 Mar.
2
High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.使用三维HepaRG球体进行高通量微核试验用于体外遗传毒性测试。
Arch Toxicol. 2023 Apr;97(4):1163-1175. doi: 10.1007/s00204-023-03461-z. Epub 2023 Feb 27.
3
Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing.
开发一种表达四种人类细胞色素P450用于遗传毒性测试的TK6衍生细胞系。
Toxicol In Vitro. 2025 Oct;108:106085. doi: 10.1016/j.tiv.2025.106085. Epub 2025 May 26.
4
Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.优化 Ames 试验中 N-亚硝胺致突变性的检测。
Regul Toxicol Pharmacol. 2024 Nov;153:105709. doi: 10.1016/j.yrtph.2024.105709. Epub 2024 Sep 28.
5
Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.使用纠错的下一代测序技术评估 N-亚硝基二甲胺在 2D 和 3D HepaRG 细胞培养物中的致突变性。
Arch Toxicol. 2024 Jun;98(6):1919-1935. doi: 10.1007/s00204-024-03731-4. Epub 2024 Apr 7.
6
Application of HepaRG cells for genotoxicity assessment: a review.HepaRG 细胞在遗传毒性评估中的应用:综述。
J Environ Sci Health C Toxicol Carcinog. 2024;42(3):214-237. doi: 10.1080/26896583.2024.2331956. Epub 2024 Apr 2.
纠错下一代测序技术推动非临床遗传毒性和致癌性检测。
Nat Rev Drug Discov. 2023 Mar;22(3):165-166. doi: 10.1038/d41573-023-00014-y.
4
Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals.药品中亚硝胺杂质的根本原因和风险因素的监管经验
J Pharm Sci. 2023 May;112(5):1166-1182. doi: 10.1016/j.xphs.2022.12.022. Epub 2023 Jan 1.
5
Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.使用转染细胞色素 P450 的人 TK6 细胞对亚硝胺杂质进行遗传毒性评估。
Arch Toxicol. 2022 Nov;96(11):3077-3089. doi: 10.1007/s00204-022-03347-6. Epub 2022 Jul 26.
6
Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.利用高通量彗星芯片平台评估体外三维 HepaRG 球体模型的遗传毒性。
ALTEX. 2022;39(4):583-604. doi: 10.14573/altex.2201121. Epub 2022 Mar 18.
7
Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations.使用两种不同培养条件优化 HepaRG 细胞系模型用于药物毒性研究:优缺点。
Arch Toxicol. 2022 Sep;96(9):2511-2521. doi: 10.1007/s00204-022-03329-8. Epub 2022 Jun 24.
8
A substructure-based screening approach to uncover N-nitrosamines in drug substances.基于亚结构的筛选方法揭示药物中的 N-亚硝胺。
J Food Drug Anal. 2022 Mar 15;30(1):150-162. doi: 10.38212/2224-6614.3400.
9
Metabolic Activation and DNA Interactions of Carcinogenic -Nitrosamines to Which Humans Are Commonly Exposed.致癌亚硝胺在人类中常见的代谢激活与 DNA 相互作用。
Int J Mol Sci. 2022 Apr 20;23(9):4559. doi: 10.3390/ijms23094559.
10
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development.药物中亚硝胺类杂质的风险评估:药物研发的未来视角。
Arch Pharm (Weinheim). 2022 Apr;355(4):e2100435. doi: 10.1002/ardp.202100435. Epub 2022 Jan 27.